Public title Effects of auricular electrical stimulation combined with back nerve block on postoperative recovery in elderly patients undergoing lung cancer surgery

Effect of Transcutaneous Auricular Vagus Nerve Stimulation Combined with Erector Spinae Plane Block on the Quality of Recovery in Elderly Patients Undergoing Thoracoscopic Lobectomy: A Prospective, Randomized, Double-Blind, Controlled Study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2600128034

Enrollment

Unknown

Registered

2026-07-13

Start date

2026-07-21

Completion date

Unknown

Last updated

2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary lobectomy

Interventions

Continuous erector spinae plane block group(cESPB):After the operation, ultrasound-guided erector spinae plane block was performed and a catheter was placed to connect the analgesic pump

Percutaneous auricular vagus nerve electrical stimulation + single erector spinae plane block group(taVNS+sESPB):taVNS was performed in the afternoon of the first day before the operation, 30 minutes

Percutaneous auricular vagus nerve electrical stimulation + continuous erector spinae plane block group(taVNS+cESPB):taVNS was performed in the afternoon of the first day before the operation, 30 minu

background infusion rate: 5ml/h

single dose of PCA: 3-5ml

locking time: 30min).

Single erector spinae plane block group (sESPB):After the operation, a single erector spinalis plane block was performed under ultrasound guidance, and intravenous patient-controlled analgesia pump wa

Eligibility

Sex/Gender

All

Age

60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Age >= 60 years; 2.Scheduled for elective thoracoscopic single lung lobectomy with an estimated operation time exceeding 1 hour; 3.American Society of Anesthesiologists (ASA) Physical Status Classification I-III, New York Heart Association (NYHA) Functional Classification I-III, able to tolerate general anesthesia and one-lung ventilation; 4.The patient or their legal representative is able to understand and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.The stimulation area (auricle) has active infection, dermatitis, or deformity; 2.Presence of an implanted cardiac pacemaker, implantable cardioverter-defibrillator (ICD), or other electronic implantable device; 3.Diagnosed severe cardiac arrhythmia; 4.Infection at the intended puncture site; 5.Known severe allergy to the local anesthetics used; 6.Presence of uncorrected severe coagulation dysfunction.

Design outcomes

Primary

Measure	Time frame
Quality of Recovery-15 (QoR-15) on postoperative days 1, 2, and 3;	—

Secondary

Measure	Time frame
Pain score;Incidence of POD;Postoperative complications;Adverse reaction;	—

Countries

China

Contacts

Public ContactZhang Congli

The First Affiliated Hospital of Bengbu Medical University

byfy1010@163.com+86 552 3158805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026